Category 1
New resource tool aims to advance women’s health research
A new government-backed platform has been launched in the US to help close the gaps in women’s health research and patient outcomes.
The U.S National Library of Medicine (NLM) and the Office of Research on Women’s Health (ORWH) have launched the Discover Women’s Health (DiscoverWHR) Resource which aims to close the gaps in women’s health research and care.
The platform has been established to act as a hub for for National Institutes of Health (NIH) resources on women’s health and to help simplify the process of finding information for medical professionals and patients.
Exploring topics such as menopause, polycystic Ovary Syndrome (PCOS), and autoimmune diseases, the site also provides resources on funding opportunities, awarded research projects, recruiting and upcoming clinical trials, the latest literature published on NIH-funded research, and patient-friendly summaries of health topics.
The site has been launched in response to the first White House Initiative on Women’s Health Research that began in 2023.
With the chronic under-representation of women in health research, the imitative aims to close this gap through advancing research and accelerating investment in the field.
The website states: “The NIH-Wide Strategic Plan for Research on the Health of Women and user feedback will guide the identification of future research areas. Additionally, DiscoverWHR will expand to include other enhancements such as common data elements, data sources, and standardised terminologies.
“The DiscoverWHR portal is envisioned to be a centralised resource for women’s health research and information from NIH that supports NIH-wide efforts to close the gaps in women’s health across the life course.
“The goal of the DiscoverWHR portal is to facilitate research discovery by sharing information on NIH-supported grants, intramural research, clinical trials, and literature on issues that directly affect women, or present differently in women, such as autoimmune disorders.
“ORWH and NLM will enhance DiscoverWHR with additional NIH-funded research topics and resources, as well as incorporate data science tools such as artificial intelligence.”
Entrepreneur
Last chance to save on Women’s Health Week and Women’s Sport Summit: Early Bird pricing ends 11 September
Early bird pricing for W Group’s two flagship October summits – Women’s Health Week Europe 2026 and Women’s Sport Summit Europe 2026 – closes on 11 September.
Both events take place at Emirates Stadium, London, bringing together founders, investors, corporates, and industry leaders shaping the future of women’s health and sport.
Women’s Health Week Europe 2026
7-8 October | Emirates Stadium, London
This year’s edition will be Women’s Health Week Europe biggest one yet: with 700+ attendees, 80+ speakers, and 20+ sponsors, it will also feature two stages – a Global Stage covering market trends and policy, and a Scale Stage focused on company-level growth and commercialisation. WHW takes place across two days of content, business matchmaking, and dealmaking.
Agenda highlights include:
- Where Capital Flows: Funding Trends in Women’s Health – with Merete Clausen (EIF), Ekaterina Gianelli (Calm/Storm), Henriette Hessen (Verdane), Jemma Day (British Business Bank), Ravit Warsha Dor (Telus Global Ventures), Tim Davis (LSEG)
- Six Feet Under-funded: Surviving the Valley of Death in Women’s Health – with Patric Stenberg (Gesynta Pharma), Valentina Milanova (Daye), Amber Vodegel (28x)
- The Women’s Health Label – Gift or Curse? · Live Debate – with Juan Camilo Arjona Ferreira (organon), Marissa Fayer (DeepLook Medical), Christian Lautner (Heal Capital), Annie Theriault (CBIV), Ida Tin (Clue)
- Passport to Scale: Taking Your Women’s Health Business Global – with Vanessa Carpenter (Femtech Across Borders), Annie Theriault (CBIV), Victorine Lançon (Daya Ventures), Dr Mridula Pore (Peppy)
Early bird pricing (ends 11 September):
| Ticket type | Early bird | Standard |
| Startups, Scaleups, Investors, Non-Profits, Government | £599 + VAT | £699 + VAT |
| Corporates, Payors & Providers | £1,799 + VAT | £1,999 + VAT |
| Service Providers & Consultants | £3,299 + VAT | £3,499 + VAT |
Register for Women’s Health Week Europe | See the full agenda for WHW
Women’s Sport Summit Europe 2026
6 October | Emirates Stadium, London
The first-ever Women’s Sport Summit expands W Group’s expertise in connecting key decision-makers to the sports industry.
WSS brings together rights holders, brands, investors, athletes, and media to accelerate commercial growth across the sector.
Agenda highlights include:
- From capital to crowd: the women’s sport cycle at scale – with Omar Shaikh (Arsenal FC), Nicole McWilliams (Google), Kerstin Lutz (Mercury13), Jo Currie (BBC Sport)
- Women’s sport through the investor lens: what gets funded – and why – Hugo Sever (APEX Capital)
- Rethinking ROI: what are we measuring that doesn’t actually matter? – Fi Watherston (Metro Bank), Silvia Keiser (Billie Jean King Cup), Gabriel Akin-Odujobi (Crux Football), Tammy Parlour (WST)
- Beyond the 90 minutes: matchday as a commercial product, not just a fixture – Maggie Murphy (Aston Villa Women FC), Sam Feasey (Diageo/Guinness), Molly Miller (OneFootball), Megan Feringa (The Athletic/The New York Times)
Early bird pricing (ends 11 September):
| Ticket type | Early bird | Standard |
| General Pass | £299 + VAT | £399 + VAT |
| Service Providers & Consultants | £1,799 + VAT | £1,999 + VAT |
Register for Women’s Sport Summit Europe | See the full agenda for WSS
Attending both events?
For group tickets or to attend both summits this October, contact Callum, W Group’s Client Success Lead, at [email protected].
By Women’s HealthX
As healthcare organisations navigate tightening compliance mandates, evolving reimbursement frameworks, and shifting health economics, the single most critical asset for leadership is operational visibility into what their industry counterparts are executing right now.
Ahead of the Women’s HealthX marketplace in Boston this December, a cross-functional steering committee of health plans, hospital networks, biopharma innovators, and enterprise employers has launched the definitive 2026 U.S. Health Infrastructure Survey.
The objective of this brief, multi-state index is to bypass abstract market fluff and map out exactly how the country’s elite healthcare stakeholders are practically structuring their 2027 budgets, clinical protocols, and technology procurement guidelines.
Some of the questions we are asking:
- Health Plans & Payers “What is the biggest operational barrier to expanding women’s health coverage?”
- Health Systems & Providers “What is the biggest women’s health priority for health systems over the next 24 months?”
- Pharma & Life Sciences “What is the biggest commercial hurdle facing women’s health innovation?”
- Employers & Benefits Leaders “Which women’s health challenge creates the greatest workforce impact?”
By contributing just 60 seconds of your operational insight to the index, you will ensure your specific sector’s parameters are accurately represented.
In return for your participation, you will secure a priority, pre-ordered copy of the completed 30-page intelligence report when the final data drops this September!
See where your direct peer groups are drawing their line in the sand for the upcoming fiscal year.
Contribute 60 seconds and pre-order your national benchmark report
Women’s HealthX 2026 | From Rhetoric to Results
Encore Boston Harbor | December 3-4 2026
Bypass abstract market rhetoric to evaluate real-world health economics, regulatory compliance mandates, and care delivery systems.
Join the region’s foremost health plan medical directors, hospital COOs, biopharma innovators, and enterprise benefits buyers anchoring our 2026 tracks.
Sponsored Content
The room is filling up at WHW Europe 2026 with super early bird pricing ending this Friday
Early bird pricing for Women’s Health Week Europe 2026 ends this Friday, and the room is already looking like one that you won’t want to miss.
A snapshot of organisations already registered includes Google, Merck, LSEG, Boots, Novo Nordisk, the Gates Foundation, MIT, HSBC, UCL, NHS England, MHRA, NICE, NIHR, British Business Bank, TELUS Global Ventures, Weber Shandwick, Verdane, Antler, Thena Capital, Calm/Storm Ventures, and a growing list of the most promising startups currently operating in the women’s health space.
700+ decision-makers, 2 days at The Emirates Stadium. Secure your place before prices increase.
What’s on the programme
For the first time, WHW Europe runs across two dedicated stages. The Global Stage covers the macro forces shaping the sector: funding trends, AI, the gender data gap, wearable technology, and European policy. The Scale Stage focuses on execution: regulatory approval pathways, building the evidence stack that wins payers, surviving the valley of death, and positioning for acquisition.
Confirmed speakers include Alison Cave (Chief Safety Officer, MHRA), Emily Darlington MP, Frida Polli (MIT), Nichole Young-Lin (Google), Merete Clausen (EIF), Kerry Buckley (Boots), Tim Davis (LSEG), Henriette Hessen (Verdane), Michael Lewis (NIHR), and Dr. Henrietta Hughes (Patient Safety Commissioner), among many others.
Early bird pricing ends this Friday
Tickets are currently available at early bird rates, with savings of up to £500 off standard pricing.
To secure your spot where women’s health comes to scale, book now.
Entrepreneur1 week agoKOVE Medical raises €1.7 million to improve safety of foetal surgery
Pregnancy2 weeks agoUK study aims to transform maternity care for high-risk pregnancies
Fertility2 days agoParacetamol use may impact future fertility, studies suggest
Entrepreneur5 days agoLast chance to save on Women’s Health Week and Women’s Sport Summit: Early Bird pricing ends 11 September
Cancer2 weeks agoArk Surgical secures further institutional backing to accelerate US expansion
Menopause1 week agoMenopause hormone treatment may ease brain fog, study suggests
Menopause4 days agoCancer drug could tackle osteoporosis menopause weight gain
News2 weeks agoSpanish agency criticised for menopause guidelines based on male studies